Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Eye cancer, intraocular melanoma
Stage/Subtype:  recurrent intraocular melanoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-5 of 5 for your search:
Start Over
Vorinostat in Treating Patients with Metastatic Melanoma of the Eye
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AAAO5917, NCI-2012-00860, CUMC-IRBAAAO5917, MSKCC-12-027, 9111, 12-027, NCT01587352
Glembatumumab Vedotin in Treating Patients with Metastatic or Locally Recurrent Uveal Melanoma
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9855, NCI-2015-00159, NCI9855, NCT02363283
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 to 99
Trial IDs: IMCgp100-202, NCI-2017-00590, NCT03070392
Sotrastaurin Acetate and Alpelisib in Treating Patients with Metastatic Uveal Melanoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AAAN4901, NCI-2015-00753, CAEB071AUS01T, NCT02273219
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MCC-18377, NCI-2016-00358, NCT02652455
Start Over